Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.
J Surg Oncol
; 74(3): 223-6, 2000 Jul.
Article
em En
| MEDLINE
| ID: mdl-10951423
ABSTRACT
BACKGROUND AND OBJECTIVES:
In ovarian cancer, development of safe and effective methods for providing long-term access to the peritoneal cavity has become increasingly important.METHODS:
A modified Port-A-Cath (Celsite-port and catheters, B. Braun, Chasseneuil, France) was used in 56 patients with presumed epithelial ovarian cancer at the conclusion of primary or second-look laparotomy. In 37 patients, ports were located on the right costal margin in the midclavicular region and in 19 in the xiphoid region.RESULTS:
In 56 catheters, 8 (13.8%) complications of severe or moderate degree during the treatment were registered. In-flow obstruction of device occurred in 6 patients, and there was 1 viscous perforation and 1 catheter related infectious peritonitis. Grade III-IV pain and in-flow obstruction were developed in the patients with ports implanted on the right costal margin but not with ports implanted in the xiphoid region.CONCLUSION:
The complication rate of intraperitoneal access devices is comparatively low.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Ovarianas
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Cateteres de Demora
/
Infusões Parenterais
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
J Surg Oncol
Ano de publicação:
2000
Tipo de documento:
Article
País de afiliação:
Turquia